Am. J. Respir. Crit. Care Med., Vol 155, No. 6, Jun 1997, 2047-2056.
Observer variation and relationship of computed tomography to severity of beryllium disease
EM Daniloff, DA Lynch, BB Bartelson, JD Newell Jr, SM Bernstein and LS Newman
Department of Medicine, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, Denver 80206, USA.
Although high resolution computed tomography (HRCT) is commonly used to
assess interstitial lung disease (ILD), relatively little is known about
interrater reliability and construct validity of HRCT-reported nodules,
ground-glass opacity, or other typical findings. We determined the
interobserver and intraobserver variability of HRCT findings and correlated
HRCT abnormalities with physiologic measures in 57 patients with chronic
beryllium disease (CBD). Reliability of HRCT scan measurements were
assessed using weighted kappa (K(W)) and intraclass correlation
coefficients. We correlated HRCT with spirometry, body plethysmographic
lung volumes, diffusing capacity for carbon monoxide (DL(CO)), maximal
exercise testing with measurement of arterial blood gases, and
bronchoalveolar lavage (BAL). Interobserver agreement for three of the HRCT
abnormalities found in CBD was moderate: the K(W) for nodules, septal
lines, and ground-glass attenuation were 0.53, 0.44, and 0.53,
respectively. Agreement was poor for bronchial wall thickening (K(W) =
0.15). HRCT scores correlated significantly with DL(CO), gas exchange at
rest and at maximal exercise, and lung volume. This study demonstrates that
HRCT has good interrater reliability and correlates with indices of the
severity of granulomatous lung diseases such as CBD.
This article has been cited by other articles:

|
 |

|
 |
 
B. Sundaram, B. H. Gross, F. J. Martinez, E. Oh, N. L. Muller, M. Schipper, and E. A. Kazerooni
Accuracy of High-Resolution CT in the Diagnosis of Diffuse Lung Disease: Effect of Predominance and Distribution of Findings
Am. J. Roentgenol.,
October 1, 2008;
191(4):
1032 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marchand-Adam, A. El Khatib, F. Guillon, M. W. Brauner, C. Lamberto, V. Lepage, J-M. Naccache, and D. Valeyre
Short- and long-term response to corticosteroid therapy in chronic beryllium disease
Eur. Respir. J.,
September 1, 2008;
32(3):
687 - 693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Maier, J. W. Martyny, J. Liang, and M. D. Rossman
Recent Chronic Beryllium Disease in Residents Surrounding a Beryllium Facility
Am. J. Respir. Crit. Care Med.,
May 1, 2008;
177(9):
1012 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Jonth, L. Silveira, T. E. Fingerlin, H. Sato, J. C. Luby, K. I. Welsh, C. S. Rose, L. S. Newman, R. M. du Bois, L. A. Maier, et al.
TGF-beta1 Variants in Chronic Beryllium Disease and Sarcoidosis
J. Immunol.,
September 15, 2007;
179(6):
4255 - 4262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. HUNNINGHAKE, M. B. ZIMMERMAN, D. A. SCHWARTZ, T. E. KING JR., J. LYNCH, R. HEGELE, J. WALDRON, T. COLBY, N. MULLER, D. LYNCH, et al.
Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
July 15, 2001;
164(2):
193 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. MAIER, M. V. RAYNOLDS, D. A. YOUNG, E. A. BARKER, and L. S. NEWMAN
Angiotensin-1 Converting Enzyme Polymorphisms in Chronic Beryllium Disease
Am. J. Respir. Crit. Care Med.,
April 1, 1999;
159(4):
1342 - 1350.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 American Thoracic Society
|
|
|